...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >in vivo evaluation of the stabilities of 52Mn-DOTA and 64Cu-DOTA using radiolabelled liposomes and PET imaging]]>
【24h】

in vivo evaluation of the stabilities of 52Mn-DOTA and 64Cu-DOTA using radiolabelled liposomes and PET imaging]]>

机译:<![cdata [脂质体的脂质体与锰-52和在体内>斜体>斜体>评估 52 Mn-dota和 64> 64 cu-dota使用放射性标记脂质体和pet映像]]>

获取原文
获取原文并翻译 | 示例
           

摘要

AbstractLiposomes are nanoparticles used in drug delivery that distribute over several days in humans and larger animals. Radiolabeling with long-lived positron emission tomography (PET) radionuclides, such as manganese-52 (52Mn, T?=5.6days), allow the imaging of this biodistribution. We report optimized protocols for radiolabeling liposomes with52Mn, through both remote-loading and surface labeling. For comparison, liposomes were also remote-loaded and surface labeled with copper-64 (64Cu, T?=12.7h) through conventional means. The chelator DOTA was used in all cases. Thein vivostability of radiometal chelates is widely debated but studies that mimic a realisticin vivosetting are lacking. Therefore, we employed these four radiolabeled liposome types as platforms to demonstrate a new concept for suchin vivoevaluation, here of the chelates52Mn-DOTA and64Cu-DOTA. This was done by comparing “shielded” remote-loaded with “exposed” surface labeled variants in a CT26 tumor-bearing mouse model. Remote loading (90min at 55°C) and surface labeling (55°C for 2h) of52Mn gave excellent radiolabeling efficiencies of 97–100% and 98–100% respectively, and the liposome biodistribution was imaged by PET for up to 8days. Liposomes with surface-conjugated52Mn-DOTA exhibited a significantly shorter plasma half-life (T?=14.4h) when compared to the remote-loaded counterpart (T?=21.3h
机译:<![cdata [ 抽象 脂质体是用于药物递送的纳米颗粒,其在人类和较大的动物中分布几天。用长寿命的正电子发射断层扫描(PET)放射性核素(如锰-52)的放射性标记( 52 mn,t?= 5.6days),允许这一点生物分布。通过远程负载和表面标记,向微小脂质体报告用于放射性标记脂质体的优化方案。为了比较,通过常规方法,脂质体也被遥控和用铜-64标记的表面标记( 64/44:sup> cu,t≥12.7h)。在所有情况下使用螯合剂DotA。在体内斜体>放射素螯合物的稳定性是广泛的争论,但研究了模仿现实的在体内设置缺乏。因此,我们使用这四种放射性标记的脂质体类型作为展示这种斜体>斜体>评估中的新概念,这里的螯合物 52 mn-dota和 64 cu-dota。这是通过比较CT26携带CT26肿瘤鼠标模型中的“暴露”表面标记的变体进行比较“屏蔽”遥控器来完成的。远程加载(在55℃下90mIn)和表面标记(55℃,2h) 52> 52:sup> Mn给出了97-100%和98-的优异放射性标记效率分别为100%,脂肪体生物分布通过PET成像,最多80天。具有表面缀合的脂质体 52> sup> mn-dota表现出显着较短的等离子体半衰期(t = 21.3h

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号